NDC 63323-485-41 - Xylocaine
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63323-485
- Requested NDC
- 63323-485-41
- Package NDCs from labels
- 63323-485-41, 63323-485-26, 63323-485-01, 63323-485-27, 63323-485-03, 63323-485-57
- Manufacturer
- Henry Schein, Inc.
- Effective date
- 2026-11-13
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Xylocaine 1% (10mg/mL) | Henry Schein, Inc. | 2026-11-13 | HUMAN PRESCRIPTION DRUG LABEL |
| XYLOCAIN (LIDOCAINE HCl ) - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2025-05-07 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine MPF - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2025-04-22 | HUMAN PRESCRIPTION DRUG LABEL |
| XYLOCAINE - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2024-01-27 | HUMAN PRESCRIPTION DRUG LABEL |
| XYLOCAINE - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2024-01-22 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine 1% (10mg/mL) | General Injectables and Vaccines, inc. | 2022-12-22 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine MPF - Fresenius Kabi USA, LLC | Fresenius Kabi Austria | Fresenius Kabi USA, LLC | Fresenius Kabi Austria | 2021-08-25 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine - Cardinal Health | Cardinal Health | 2020-06-08 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine MPF - Cardinal Health | Cardinal Health | 2019-09-09 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine | REMEDYREPACK INC. | 2019-04-30 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine | Physicians Total Care, Inc. | 2012-02-09 | HUMAN PRESCRIPTION DRUG LABEL |
| Xylocaine - General Injectables & Vaccines, Inc | General Injectables & Vaccines, Inc | 2011-09-26 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63323-485-01 | Xylocaine | 20 mL in 1 VIAL, MULTI-DOSE | INJECTION, SOLUTION | 20 | 13 | |
| 63323-485-03 | Xylocaine | 50 mL in 1 VIAL, MULTI-DOSE | INJECTION, SOLUTION | 50 | 13 | |
| 63323-485-27 | Xylocaine | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 13 | |
| 63323-485-57 | Xylocaine | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 13 | |
| 63323-485-26 | Xylocaine | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 7 | |
| 63323-485-41 | Xylocaine | 20 mL in 1 VIAL, MULTI-DOSE | INJECTION, SOLUTION | 20 | 7 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63323-485 | XYLOCAINE MPF (LIDOCAINE HYDROCHLORIDE) INJECTION, SOLUTION XYLOCAINE (LIDOCAINE HYDROCHLORIDE) INJECTION, SOLUTION XYLOCAINE MPF (LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 13 | Current NDC, Legacy NDC, 4 package rows | 20210831_ba082c2f-64f4-419d-9c88-74f203316e17.zip |
| 63323-485 | XYLOCAINE MPF (LIDOCAINE HYDROCHLORIDE) INJECTION, SOLUTION XYLOCAINE (LIDOCAINE HYDROCHLORIDE) INJECTION, SOLUTION XYLOCAINE (LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 7 | Current NDC, Legacy NDC, 2 package rows | 20250515_4dd52202-8eef-4136-92dd-ada573b7cf74.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63323-485-01 | ML - Milliliter | 63323-485 | 55c3520d-d402-4267-87fe-ec239a7384ea | 1 | 2019-12-10 |
| 63323-485-03 | ML - Milliliter | 63323-485 | 8152cfd7-4dd8-49cd-8f86-c8e56a346d48 | 1 | 2019-12-10 |
| 63323-485-26 | ML - Milliliter | 63323-485 | 2b9ff4f4-641e-4bb5-9378-b0f143bdac48 | 1 | 2016-09-02 |
| 63323-485-27 | ML - Milliliter | 63323-485 | 84d0434d-5c06-4795-baaa-4cf67cf1a8e9 | 1 | 2012-07-24 |
| 63323-485-41 | ML - Milliliter | 63323-485 | 7ad5e0f1-7fc8-4e2c-949a-b8a6bf1a6808 | 1 | 2020-07-13 |
| 63323-485-57 | ML - Milliliter | 63323-485 | fcef2f79-20f4-4731-a3c6-7c153a2919bb | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 5Kind Maximum Strength Pain Relieving Lidocaine HCl Hemp | LIDOCAINE HYDROCHLORIDE | 5Kind Trading LTD | c2df4c90-2b9e-460a-8f54-5d824b484163 | 2026-10-02 | Warnings | V13007Z41A |
| Sal de Uvas Picot | CITRIC ACID MONOHYDRATE AND SODIUM BICARBONATE | Navajo Manufacturing Company Inc. | 5d6d297d-770b-dd9f-e063-6294a90a4bb8 | 2026-10-02 | Warnings | 2968PHW8QP |
| Meijer Maximum strength pain relieving cleansing | BENZALKONIUM CHLORIDE AND LIDOCAINE HYDROCHLORIDE | MEIJER DISTRIBUTION, INC. | d7d63abe-d1ff-4a8d-bfa7-35c63dfbf857 | 2026-10-01 | Warnings | V13007Z41A |
| First Aid Only First Aid/Burn Cream | BENZALKONIUM CHLORIDE, LIDOCAINE HYDROCHLORIDE CREAM | Acme United Corporation | 5cc8418f-a285-4240-e063-6294a90a7bf3 | 2026-10-01 | Warnings | V13007Z41A |
| BVibe | LIDOCAINE HCL DELAY SPRAY | COTR Inc | 39bfb77f-090a-9ef1-e063-6294a90a5644 | 2026-09-29 | Warnings | V13007Z41A |
| Dextrose And Sodium Chloride | DEXTROSE AND SODIUM CHLORIDE | B. Braun Medical Inc. | 8e6569ce-9714-497f-a94b-c6975c1d76f6 | 2026-09-28 | Warnings, Adverse reactions | 451W47IQ8X |
| Lidocaine hydrochloride | LIDOCAINE HYDROCHLORIDE | American Health Packaging | 0a36a6de-40d5-41ba-bb5f-39d36c267b7f | 2026-09-24 | Boxed warning, Warnings, Adverse reactions | V13007Z41A |
| Sodium Chloride Hypertonicity Ophthalmic | SODIUM CHLORIDE | Rugby Laboratories | 7546770d-bc12-44b8-9fe0-fc3f5e1d12d1 | 2026-09-24 | Warnings | 451W47IQ8X |
| American Red Cross First Aid | BENZALKONIUM CHLORIDE, LIDOCAINE HYDROCHLORIDE | MY IMPORTS USA, LLC | 667ab8ce-e110-4b7f-a158-3cdd3b7a1c29 | 2026-09-23 | Warnings | V13007Z41A |
| Sodium Chlorode Hypertonicity Ophthalmic Solution | SODIUM CHLORIDE | Rugby Laboratories | 822d25c0-71b3-421d-b702-4cded0c4ca32 | 2026-09-23 | Warnings | 451W47IQ8X |
| BURBLE | SODIUM CHLORIDE | LETS BURBLE, INC. | 17f48d4f-907c-3829-e063-6394a90ab202 | 2026-09-22 | Warnings | 451W47IQ8X |
| HEB Saline | NASAL | HEB | 520e20a3-1e16-4cbd-9da3-948747f4f51d | 2026-09-18 | Warnings | 451W47IQ8X |
| Lidocaine Hydrochloride and Epinephrine | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE | Hospira, Inc. | 2f94f711-14c4-48ec-c5a3-c5ec4b8e8729 | 2026-09-17 | Warnings, Adverse reactions | 1010751 1867996 1010688 1010759 1010745 V13007Z41A |
| Lymph Tonic II | ECHINACEA (ANGUSTIFOLIA), COLLINSONIA CANADENSIS, PHYTOLACCA DECANDRA, KALI IODATUM, PINUS SYLVESTRIS, PIX LIQUIDA, FERRUM PHOSPHORICUM, AESCULUS HIPPOCASTANUM, BARYTA CARBONICA, BERBERIS VULGARIS, CALCAREA CARBONICA, CALCAREA PHOSPHORICA, CAUSTICUM, HEPAR SULPHURIS CALCAREUM, KREOSOTUM, LYCOPODIUM CLAVATUM, MERCURIUS SOLUBILIS, NATRUM MURIATICUM, NITRICUM ACIDUM, PHOSPHORUS, PULSATILLA (PRATENSIS), SILICEA, STELLARIA MEDIA, SULPHUR, TEREBINTHINA, THUJA OCCIDENTALIS, BUFO RANA | BioActive Nutritional, Inc. | 0e3265b0-b210-4a4c-80d2-8a9712981d4e | 2026-09-17 | Warnings | 451W47IQ8X |
| Saline | SALINE | FAMILY DOLLAR SERVICES INC | 7d2acfff-e55b-48b9-9d36-4975563e08ff | 2026-09-17 | Warnings | 451W47IQ8X |
| 5Kind Neurophase Pro Pain Relieving | LIDOCAINE HYDROCHLORIDE, MENTHOL | 5KIND TRADING LTD | 72759a1a-6751-4c00-944c-018c2e5f9170 | 2026-09-16 | Warnings | V13007Z41A |
| Dragon Lidocaine Pain | LIDOCAINE HYDROCHLORIDE | Genomma Lab USA | 7f29acd2-a287-4553-a851-c16b183edea6 | 2026-09-16 | Warnings | V13007Z41A |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE ANHYDROUS | Henry Schein, Inc. | 07a2b40b-0386-40d4-b0c4-e69e13610cd9 | 2026-09-14 | Warnings, Adverse reactions | 1010033 V13007Z41A |
| Lidocaine 4% Cream | LIDOCAINE 4% | InvaDerm Corporation | 5b3c6a39-f094-8c2d-e063-6394a90a94c3 | 2026-09-11 | Warnings | V13007Z41A |
| LIDOCAINE HYDROCHLORIDE | LIDOCAINE HYDROCHLORIDE | Henry Schein, Inc. | 23c8f711-e458-479a-9ab0-dcc851311e24 | 2026-09-10 | Warnings, Adverse reactions | 1737761 V13007Z41A |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.